Abstract
J Pharmacol Exp Ther 362(1):200–209; DOI: 10.1124/jpet.117.241604], the following funding information was omitted: This work was supported by U.S. Public Health Service grants from the National Institutes of Health National Institute on Drug Abuse [Grant R01 DA 024865] (KAB) and Training Grant T32 DA031115] (LCS); National Institute of General Medical Sciences [Grant R01 GM106035] (KAB); and the National Institute of Neurological Disorders and Stroke [Training Grant T32 NS082145] (M.M.P.). The authors regret this error and any inconvenience it may have caused.
Original language | English (US) |
---|---|
Pages (from-to) | 143 |
Number of pages | 1 |
Journal | Journal of Pharmacology and Experimental Therapeutics |
Volume | 369 |
Issue number | 1 |
DOIs |
|
State | Published - Apr 2019 |
ASJC Scopus subject areas
- Molecular Medicine
- Pharmacology